Aptevo Therapeutics (APVO) Institutional Ownership $4.41 -0.12 (-2.65%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)CurrentInstitutional OwnershipPercentage8.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$313.86MNumber ofInstitutional Sellers(last 12 months)0 Get APVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APVO Institutional Buying and Selling by Quarter Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Aptevo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC749,234$229K0.0%N/A18.359% 11/15/2023 Sabby Management LLC1,334,169$440K0.3%N/A11.581% 11/15/2023 Armistice Capital LLC1,235,000$408K0.0%N/A10.717% 2/1/2023 Bank of Montreal Can10,000$61K0.0%N/A0.196% 11/15/2022 Cantor Fitzgerald L. P.133,700$406K0.0%N/A2.627% 11/7/2022 Virtu Financial LLC28,421$86K0.0%+122.6%0.558% Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/10/2021 Towercrest Capital Management211,227$3.26M0.6%N/A4.313% 12/8/2021 Moors & Cabot Inc.389,269$3.73M0.2%N/A7.948% 11/15/2021 Franklin Resources Inc.15,650$242K0.0%N/A0.320% 11/15/2021 GSA Capital Partners LLP13,651$211K0.0%N/A0.279% 11/12/2021 Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931% 11/9/2021BlackRock Inc.55,394$856K0.0%+1.9%1.133% 11/5/2021 Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954% 8/17/2021 Balyasny Asset Management LLC18,012$404K0.0%-70.6%0.405% 8/17/2021 Boothbay Fund Management LLC15,350$344K0.0%+4.9%0.345% 8/16/2021 Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127% 8/16/2021 Morgan Stanley8,364$187K0.0%+163.4%0.188% 8/16/2021 Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225% 8/16/2021 State Street Corp10,973$246K0.0%N/A0.247% 8/13/2021 Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594% 8/13/2021 Anson Funds Management LP35,587$798K0.1%-26.6%0.800% 8/13/2021 Northern Trust Corp22,652$508K0.0%+170.7%0.509% 8/13/2021QS Investors LLC15,650$352K0.0%+37.3%0.352% 8/13/2021 Geode Capital Management LLC38,917$872K0.0%+8.8%0.875% 8/13/2021 Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028% 5/17/2021 Schonfeld Strategic Advisors LLC9,700$296K0.0%-12.6%0.218% 5/14/2021 RTW Investments LP281,402$8.59M0.1%-2.4%6.324% 5/14/2021 Dynamic Technology Lab Private Ltd14,022$428K0.0%+6.2%0.315% 5/13/2021QS Investors LLC11,400$348K0.0%N/A0.256% 5/13/2021 JBF Capital Inc.3,907$119K0.0%+49.9%0.088% 5/13/2021 Renaissance Technologies LLC209,223$6.39M0.0%-17.8%4.702% 5/13/2021 Bank of New York Mellon Corp9,964$305K0.0%N/A0.224% 5/13/2021 Bank of Montreal Can25,280$674K0.0%-20.1%0.568% 5/12/2021 Geode Capital Management LLC35,762$1.09M0.0%+26.8%0.804% 5/7/2021BlackRock Inc.57,605$1.76M0.0%-1.0%1.294% 3/8/2021 Dimensional Fund Advisors LP5,502$202K0.0%N/A0.126% 2/25/2021 Dimensional Fund Advisors LP5,502$202K0.0%N/A0.126% 2/24/2021 Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133% 2/18/2021 Ghost Tree Capital LLC50,000$1.83M0.4%N/A1.142% 2/16/2021 Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133% Combine the QQQ, IWM and SPY in one trade (Ad)If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here.2/16/2021 Pura Vida Investments LLC8,203$301K0.0%N/A0.187% 2/16/2021 Price T Rowe Associates Inc. MD6,300$231K0.0%N/A0.144% 2/12/2021 Stonepine Capital Management LLC18,280$670K0.5%N/A0.417% 2/11/2021 JBF Capital Inc.2,607$96K0.0%N/A0.060% 2/11/2021 Northern Trust Corp8,707$319K0.0%N/A0.199% 2/11/2021 Citigroup Inc.967$35K0.0%N/A0.022% 2/11/2021 Dynamic Technology Lab Private Ltd13,202$484K0.1%N/A0.301% 2/10/2021 Renaissance Technologies LLC254,423$9.33M0.0%-13.1%5.810% 2/9/2021 Wells Fargo & Company MN1,552$57K0.0%+241.1%0.035% 2/5/2021BlackRock Inc.58,168$2.13M0.0%+166.8%1.328% (Data available from 1/1/2016 forward) APVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APVO shares? During the previous two years, the following institutional investors and hedge funds held shares of Aptevo Therapeutics shares: Sabby Management LLC ($440K), and Armistice Capital LLC ($229K), Bank of Montreal Can ($61K).Learn more on APVO's institutional investors. What percentage of Aptevo Therapeutics stock is owned by institutional investors? 8.06% of Aptevo Therapeutics stock is owned by institutional investors. Learn more on APVO's institutional investor holdings. Which institutional investors have been buying Aptevo Therapeutics stock? The following institutional investors have purchased Aptevo Therapeutics stock in the last 24 months: Armistice Capital LLC ($1.98M), Sabby Management LLC ($1.33M), and Bank of Montreal Can ($10K). How much institutional buying is happening at Aptevo Therapeutics? Institutional investors have bought a total of 3,328,403 shares in the last 24 months. This purchase volume represents approximately $52.78B in transactions. Related Companies COEP Major Shareholders SNGX Major Shareholders NLSP Major Shareholders EVOK Major Shareholders EYEN Major Shareholders ADIL Major Shareholders GRI Major Shareholders GLTO Major Shareholders TRIB Major Shareholders ABVC Major Shareholders This page (NASDAQ:APVO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
